Rachael C Walker1,2, Rachael L Morton3, Suetonia C Palmer4,5, Mark R Marshall6,7,8, Allison Tong9,10, Kirsten Howard9. 1. School of Public Health and rachaelwalker14@gmail.com. 2. Renal Department, Hawke's Bay District Health Board, Hawke's Bay, New Zealand. 3. National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia. 4. Department of Nephrology, Christchurch Hospital, Christchurch, New Zealand. 5. Department of Medicine, University of Otago, Christchurch, New Zealand. 6. Baxter Healthcare (Asia-Pacific), Shanghai, China. 7. School of Medicine, University of Auckland, Auckland, New Zealand. 8. Department of Renal Medicine, Counties Manukau Health, Auckland, New Zealand; and. 9. School of Public Health and. 10. Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, New South Wales, Australia.
Abstract
BACKGROUND AND OBJECTIVES: Improved knowledge about factors that influence patient choices when considering dialysis modality could facilitate health care interventions to increase rates of home dialysis. We aimed to quantify the attributes of dialysis care and the tradeoffs that patients consider when making decisions about dialysis modalities. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted a prospective, discrete choice experiment survey with random parameter logit analysis to quantify preferences and tradeoffs for attributes of dialysis treatment in 143 adult patients with CKD expected to require RRT within 12 months (predialysis). The attributes included schedule flexibility, patient out of pocket costs, subsidized transport services, level of nursing support, life expectancy, dialysis training time, wellbeing on dialysis, and dialysis schedule (frequency and duration). We reported outcomes using β-coefficients with corresponding odds ratios and 95% confidence intervals for choosing home-based dialysis (peritoneal dialysis or hemodialysis) compared with facility hemodialysis. RESULTS: Home-based therapies were significantly preferred with the following attributes: longer survival (odds ratio per year, 1.63; 95% confidence interval, 1.25 to 2.12), increased treatment flexibility (odds ratio, 9.22; 95% confidence interval, 2.71 to 31.3), improved wellbeing (odds ratio, 210; 95% confidence interval, 15 to 2489), and more nursing support (odds ratio, 87.3; 95% confidence interval, 3.8 to 2014). Respondents were willing to accept additional out of pocket costs of approximately New Zealand $400 (United States $271) per month (95% confidence interval, New Zealand $333 to $465) to receive increased nursing support. Patients were willing to accept out of pocket costs of New Zealand $223 (United States $151) per month (95% confidence interval, New Zealand $195 to $251) for more treatment flexibility. CONCLUSIONS: Patients preferred home dialysis over facility-based care when increased nursing support was available and when longer survival, wellbeing, and flexibility were expected. Sociodemographics, such as age, ethnicity, and income, influenced patient choice.
BACKGROUND AND OBJECTIVES: Improved knowledge about factors that influence patient choices when considering dialysis modality could facilitate health care interventions to increase rates of home dialysis. We aimed to quantify the attributes of dialysis care and the tradeoffs that patients consider when making decisions about dialysis modalities. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted a prospective, discrete choice experiment survey with random parameter logit analysis to quantify preferences and tradeoffs for attributes of dialysis treatment in 143 adult patients with CKD expected to require RRT within 12 months (predialysis). The attributes included schedule flexibility, patient out of pocket costs, subsidized transport services, level of nursing support, life expectancy, dialysis training time, wellbeing on dialysis, and dialysis schedule (frequency and duration). We reported outcomes using β-coefficients with corresponding odds ratios and 95% confidence intervals for choosing home-based dialysis (peritoneal dialysis or hemodialysis) compared with facility hemodialysis. RESULTS: Home-based therapies were significantly preferred with the following attributes: longer survival (odds ratio per year, 1.63; 95% confidence interval, 1.25 to 2.12), increased treatment flexibility (odds ratio, 9.22; 95% confidence interval, 2.71 to 31.3), improved wellbeing (odds ratio, 210; 95% confidence interval, 15 to 2489), and more nursing support (odds ratio, 87.3; 95% confidence interval, 3.8 to 2014). Respondents were willing to accept additional out of pocket costs of approximately New Zealand $400 (United States $271) per month (95% confidence interval, New Zealand $333 to $465) to receive increased nursing support. Patients were willing to accept out of pocket costs of New Zealand $223 (United States $151) per month (95% confidence interval, New Zealand $195 to $251) for more treatment flexibility. CONCLUSIONS:Patients preferred home dialysis over facility-based care when increased nursing support was available and when longer survival, wellbeing, and flexibility were expected. Sociodemographics, such as age, ethnicity, and income, influenced patient choice.
Authors: Rachael C Walker; Camilla S Hanson; Suetonia C Palmer; Kirsten Howard; Rachael L Morton; Mark R Marshall; Allison Tong Journal: Am J Kidney Dis Date: 2015-01-10 Impact factor: 8.860
Authors: Rachael L Morton; Paul Snelling; Angela C Webster; John Rose; Rosemary Masterson; David W Johnson; Kirsten Howard Journal: Am J Kidney Dis Date: 2012-03-13 Impact factor: 8.860
Authors: Allison Tong; Brian Lesmana; David W Johnson; Germaine Wong; Denise Campbell; Jonathan C Craig Journal: Am J Kidney Dis Date: 2012-11-21 Impact factor: 8.860
Authors: Allison Tong; Suetonia Palmer; Braden Manns; Jonathan C Craig; Marinella Ruospo; Letizia Gargano; David W Johnson; Jörgen Hegbrant; Måns Olsson; Steven Fishbane; Giovanni F M Strippoli Journal: BMJ Open Date: 2013-01-24 Impact factor: 2.692
Authors: Oanh Kieu Nguyen; Miguel A Vazquez; Lakeesha Charles; Joseph R Berger; Henry Quiñones; Richard Fuquay; Joanne M Sanders; Kandice A Kapinos; Ethan A Halm; Anil N Makam Journal: JAMA Intern Med Date: 2019-02-01 Impact factor: 21.873
Authors: Jennifer E Flythe; Derek Forfang; Nieltje Gedney; David M White; Caroline Wilkie; Kerri L Cavanaugh; Raymond C Harris; Mark Unruh; Grace Squillaci; Melissa West; Carol Mansfield; Cindy S Soloe; Katherine Treiman; Dallas Wood; Frank P Hurst; Carolyn Y Neuland; Anindita Saha; Murray Sheldon; Michelle E Tarver Journal: Kidney360 Date: 2022-05-05
Authors: Caroline E Sloan; Cynthia J Coffman; Linda L Sanders; Matthew L Maciejewski; Shoou-Yih D Lee; Richard A Hirth; Virginia Wang Journal: Clin J Am Soc Nephrol Date: 2019-11-21 Impact factor: 8.237
Authors: Virginia Wang; Cynthia J Coffman; Linda L Sanders; Abby Hoffman; Caroline E Sloan; Shoou-Yih D Lee; Richard A Hirth; Matthew L Maciejewski Journal: Med Care Date: 2021-02-01 Impact factor: 3.178
Authors: Jenny I Shen; Lucia Chen; Sitaram Vangala; Lynn Leng; Anuja Shah; Anjali B Saxena; Jeffrey Perl; Keith C Norris Journal: Kidney Med Date: 2020-02-11